Antiviral activity of Arbidol against Coxsackie virus B5 in vitro and in vivo

Archives of Virology

Volumn 154, Issue 4, 2009, Pages 601-607

  Zhong, Qiong ^a,b   Yang, Zhanqiu ^a   Liu, Yuanyuan ^a   Deng, Haiying ^a   Xiao, Hong ^a   Shi, Liqiao ^a   He, Jing ^a  

^a WUHAN UNIVERSITY   (China)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; ARBIDOL; INDOLE DERIVATIVE;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CELL LINE; COXSACKIE VIRUS INFECTION; DRUG EFFECT; ENTEROVIRUS; HEART; HUMAN; IC 50; LUNG; MALE; MOUSE; SURVIVAL; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; COXSACKIEVIRUS INFECTIONS; ENTEROVIRUS B, HUMAN; HEART; HUMANS; INDOLES; INHIBITORY CONCENTRATION 50; LUNG; MALE; MICE; MICE, INBRED BALB C; SURVIVAL ANALYSIS;

ANIMALIA; COXSACKIEVIRUS; MUS;

EID: 64249161964     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-009-0346-4     Document Type: Article

References (28)

1. J Fohlman K Pauksen B Morein U Bjare NG Ilback G Friman 1993 High yield production of an inactivated coxsackie B3 adjuvant vaccine with protective effect against experimental myocarditis Scand J Infect Dis Suppl 88 103 108
2. DN Galbraith C Nairn GB Clements 1997 Evidence for enteroviral persistence in humans J Gen Virol 78 Pt 2 307 312
3. P Muir F Nicholson SJ Illavia TS McNeil JF Ajetunmobi H Dunn WG Starkey KN Reetoo NR Cary J Parameshwar JE Banatvala 1996 Serological and molecular evidence of enterovirus infection in patients with end-stage dilated cardiomyopathy Heart 76 243 249
4. AI Ramsingh N Chapman S Tracy 1997 Coxsackieviruses and diabetes Bioessays 19 793 800
5. BB Hamby MA Pallansch OM Kew 1987 Reemergence of an epidemic coxsackievirus B5 genotype J Infect Dis 156 288 292
6. HA Rotbart 2002 Treatment of picornavirus infections Antiviral Res 53 83 98
7. A Henke E Wagner JL Whitton R Zell A Stelzner 1998 Protection of mice against lethal coxsackievirus B3 infection by using DNA immunization J Virol 72 8327 8331
8. A Henke R Zell A Stelzner 2001 DNA vaccine-mediated immune responses in Coxsackie virus B3-infected mice Antiviral Res 49 49 54
9. L Carrasco 1994 Picornavirus inhibitors Pharmacol Ther 64 215 290
10. JC Lenzo GR Shellam CM Lawson 2001 Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice Antimicrob Agents chemother 45 1444 1449
11. C Baykurt K Caglar N Ceviz C Akyuz G Secmeer 1999 Successful treatment of Epstein-Barr virus infection associated with myocarditis Pediatr Int 41 389 391
12. R Rich M McErlean 1993 Complete heart block in a child with varicella Am J Emerg Med 11 602 605
13. A Garozzo CC Cutri A Castro G Tempera F Guerrera MC Sarva E Geremia 2000 Anti-rhinovirus activity of 3-methylthio-5-aryl-4-isothiazolecarbonitrile derivatives Antiviral Res 45 199 210
14. IA Leneva IT Fediakina TA Gus'kova RG Glushkov 2005 Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A Ter Arkh 77 84 88
15. IA Leneva MV Sokolova IT Fediakina ML Khristova NI Fadeeva TA Gus'kova 2002 Study of the effect of antiviral drugs on the reproduction of the respiratory syncytial virus by enzyme immunoassay Vopr Virusol 47 42 45
16. YS Boriskin IA Leneva EI Pécheur SJ Polyak 2008 Arbidol: a broad-spectrum antiviral compound that blocks viral fusion Curr Med Chem 15 997 1005
17. MJ Brooks JJ Sasadeusz GA Tannock 2004 Antiviral chemotherapeutic agents against respiratory viruses: where are we now and what's in the pipeline? Curr Opin Pulm Med 10 197 203
18. H Chai Y Zhao C Zhao P Gong 2006 Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 6-bromo-5-hydroxy-1H-indole-3-carboxylates Bioorg Med Chem 14 911 917
19. YS Boriskin EI Pecheur SJ Polyak 2006 Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection Virol J 3 56
20. L Shi H Xiong J He H Deng Q Li Q Zhong W Hou L Cheng H Xiao Z Yang 2007 Antiviral activity of arbidol against influenza A virus, respiratory syncytial virus, rhinovirus, coxsackie virus and adenovirus in vitro and in vivo Arch Virol 152 1447 1455
21. AF Reed 1938 A left superior vena cava draining the blood from a closed coronary sinus J Anat 73 195 197
22. Y Li PP But VE Ooi 2005 Antiviral activity and mode of action of caffeoylquinic acids from Schefflera heptaphylla (L.) Frodin Antiviral Res 68 1 9
23. TA Guskova IA Leneva IT Fedyakina VV Chistyakov RG Glushkov 1999 Arbidol kinetics and its effect on influenza A virus replication in MDCK cell culture Chemico Pharmaceut J 6 14 17
24. H Yamamoto K Yoshida Y Kondo K Inoue 1998 Production of cornoside in Abeliophyllum distichum cell suspension cultures Photochemistry 48 273 277
25. JL Schulman 1968 Effect of l-amantanamine hydrochloride (amantadine HCl) and methyl-l-adamantanethylamine hydrochloride (rimantadine HCl) on teansmission of influenza virus infection in mice Proc Soc Exp Biol Med 128 1173 1178
26. Anonymous 1999 Arbidol Drugs R D 2 171 172
27. J White J Kartenbeck A Helenius 1982 Membrane fusion activity of influenza virus Embo J 1 217 222
28. Guskova TA, Glushkov RG (1999) Arbidol: a new antiviral, immunomodulator and interferon-inducer. Timotech, Moscow